Quantifying the Impact of Atrial Fibrillation on Heart Failure-Related Patient-Reported Outcomes in the Utah mEVAL

Benjamin A Steinberg1, Mingyuan Zhang1, Jason Bensch1

  • 1University of Utah Health Sciences Center, Salt Lake City, Utah.

Insights

Atrial fibrillation (AF) significantly worsens health-related quality of life for heart failure (HF) patients. This study found that AF independently reduces quality of life and physical function in HF patients, highlighting a need for further research.

Area of Science:

  • Cardiology
  • Health Services Research
  • Patient-Reported Outcomes

Background:

  • Atrial fibrillation (AF) often co-occurs with heart failure (HF), negatively impacting patient quality of life.
  • Both AF and HF are independently linked to reduced health-related quality of life.
  • Quantifying the additional burden of AF on HF patients' quality of life is crucial for clinical practice.

Purpose of the Study:

  • To determine the incremental impact of atrial fibrillation (AF) on the health-related quality of life in patients with heart failure (HF).
  • To analyze patient-reported outcomes (PROs) in HF patients with and without AF.

Main Methods:

  • Utilized data from the Utah mEVAL program for patient-reported outcomes analysis.
  • Compared Kansas City Cardiomyography Questionnaire (KCCQ) scores and generic PROs between HF patients with and without AF.
  • Adjusted for baseline characteristics to isolate the effect of AF on quality of life.

Main Results:

  • Among 1707 HF patients, 36% had AF. Patients with HF and AF were older and had higher rates of prior stroke and ischemic cardiomyopathy.
  • Adjusted analyses revealed that HF with AF was associated with significantly worse KCCQ scores (mean difference -3.45) and PROMIS physical function scores (mean difference -1.63).
  • Differences in general health (visual analog scale) were borderline, and PROMIS depression scores were similar between groups.

Conclusions:

  • Atrial fibrillation complicates nearly one-third of heart failure cases, often in older, sicker patients.
  • AF is independently associated with worse disease-specific and overall health-related quality of life in HF patients.
  • Further research is warranted to investigate if maintaining sinus rhythm can improve health status in HF patients with AF.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
603
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
81
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
113
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
55
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
63